ISSN: 1838-7640Theranostics
Global reach, higher impact
Theranostics 2021; 11(20):9937-9952. doi:10.7150/thno.65480 This issue Cite
Review
Targeting ferroptosis-based cancer therapy using nanomaterials: strategies and applications
1. The Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, Guangdong, 524023, China.
2. The Marine Biomedical Research Institute of Guangdong Zhanjiang, Zhanjiang, Guangdong, 524023, China.
3. Southern Marine Science and Engineering Guangdong Laboratory (Zhanjiang), Zhanjiang, Guangdong, 524023, China.
4. The First Clinical College, Guangdong Medical University, Zhanjiang, Guangdong, 524023, China.
5. Experimental Animal Center, Guangdong Medical University, Zhanjiang, Guangdong, 524023, China.
6. Affiliations Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.
7. Guangdong Provincial Key Laboratory of Food Quality and Safety, College of Food Science, South China Agricultural University, Guangzhou, 510642, China.
Citation:
Luo L, Wang H, Tian W, Li X, Zhu Z, Huang R, Luo H. Targeting ferroptosis-based cancer therapy using nanomaterials: strategies and applications. Theranostics 2021; 11(20):9937-9952. doi:10.7150/thno.65480. https://www.thno.org/v11p9937.htm
Other stylesAbstract
As an iron-dependent mode of programmed cell death induced by lipid peroxidation, ferroptosis plays an important role in cancer therapy. The metabolic reprogramming in tumor microenvironment allows the possibility of targeting ferroptosis in cancer treatment. Recent studies reveal that nanomaterials targeting ferroptosis have prospects for the development of new cancer treatments. However, the design ideas of nanomaterials targeting ferroptosis sometimes vary. Therefore, in addition to the need for a systematic summary of these ideas, new ideas and insights are needed to make possible the construction of nanomaterials for effectively targeting this cell death pathway. At the same time, further optimization of nanomaterials design is required to make them appropriate for clinical treatment. In this context, we summarize this cross-cutting research area covering from the known mechanism of ferroptosis to providing feasible ideas for nanomaterials design as well as their clinical application. We aim to provide new insights and enlightenment for the next step in developing new nanomaterials for cancer treatment.
Keywords: Ferroptosis, Nanomaterials, Cancer therapy, Tumor microenvironment, Clinical strategy
Citation styles
APA
Luo, L., Wang, H., Tian, W., Li, X., Zhu, Z., Huang, R., Luo, H. (2021). Targeting ferroptosis-based cancer therapy using nanomaterials: strategies and applications. Theranostics, 11(20), 9937-9952. https://doi.org/10.7150/thno.65480.
ACS
Luo, L.; Wang, H.; Tian, W.; Li, X.; Zhu, Z.; Huang, R.; Luo, H. Targeting ferroptosis-based cancer therapy using nanomaterials: strategies and applications. Theranostics 2021, 11 (20), 9937-9952. DOI: 10.7150/thno.65480.
NLM
Luo L, Wang H, Tian W, Li X, Zhu Z, Huang R, Luo H. Targeting ferroptosis-based cancer therapy using nanomaterials: strategies and applications. Theranostics 2021; 11(20):9937-9952. doi:10.7150/thno.65480. https://www.thno.org/v11p9937.htm
CSE
Luo L, Wang H, Tian W, Li X, Zhu Z, Huang R, Luo H. 2021. Targeting ferroptosis-based cancer therapy using nanomaterials: strategies and applications. Theranostics. 11(20):9937-9952.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.